The DOI matches its Crossref record.
Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
Open accessAbstract
Summary: Myeloproliferative disorders (MPD) are reported in 25–65% of patients with splanchnic vein thrombosis (SVT). Diagnostic criteria for MPD have not been fully established in this context. Using clusters of abnormal megakaryocytes in bone marrow (BM) biopsy as a reference standard for Philadelphia negative MPD, we assessed the relevance of other criteria currently recommended for the diagnosis of MPD in SVT (128 consecutive SVT patients). First, usual criteria were compared with BM results: endogenous erythroid colony formation (EEC) was strongly correlated with BM results; splenomegaly, blood cell count, total red cell volume, erythropoietin level and cytogenetic were much less accurate. Then, patients were assigned to three groups according to the combination of BM and EEC findings (group I: both present; group II: both absent; group III: other patients); clinical presentation and outcome were compared in each group. At a mean follow‐up of 6·09 ± 6·6 years, progression to a severe form of MPD occurred in 7 of 31 group I patients (23%), in 1 of 34 group III patients (3%) and 0 of 63 group II patients. The combination of marked splenomegaly and platelet count >200 × 10 9/l was restricted to groups I and III. In conclusion, in patients with SVT, BM findings and EEC allowed the diagnosis of MPD at risk of aggravation. Marked splenomegaly in association with platelet counts >200 × 10 9/l constitute a simple index with high specificity but low sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Self-citationEASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00004 · Cited by 532
Self-citationMyeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
Smalberg, J. H., Arends, L. R., Valla, D. C., Kiladjian, J.-J., Janssen, H. L. A., & Leebeek, F. W. G. (2012) · Blood · doi:10.1182/blood-2011-09-376517 · Cited by 377
Self-citationKiladjian, J.-J., Cervantes, F., Leebeek, F. W. G., Marzac, C., Cassinat, B., Chevret, S., Cazals-Hatem, D., Plessier, A., Garcia-Pagan, J.-C., Murad, S. D., et al. (2008) · Blood · doi:10.1182/blood-2007-11-125328 · Cited by 361
Self-citation
Metadata
- Authors
- Chait, Y., Condat, B., Cazals‐Hatem, D., Rufat, P., Atmani, S., Chaoui, D., Guilmin, F., Kiladjian, J. J., Plessier, A., Denninger, M. H., Casadevall, N., Valla, D., & Brière, J. B.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 129
- Issue
- 4
- Pages
- 553-560
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2068090349
- Cited by
- 171
- References
- 0
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05490.x
- The paper
- Chait, Y., Condat, B., Cazals‐Hatem, D., Rufat, P., Atmani, S., Chaoui, D., Guilmin, F., Kiladjian, J. J., Plessier, A., Denninger, M. H., Casadevall, N., Valla, D., & Brière, J. B. (2005). Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05490.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.